Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Psoriasis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Psoriasismarket, defines the market attractiveness level of Psoriasis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Psoriasis industry, describes the types of Psoriasis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Psoriasis market and the development prospects and opportunities of Psoriasis industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Psoriasis market in Chapter 13.
By Player:
Sun Pharma
UCB
Novartis AG
Merck
Johnson & Johnson
Eli Lilly & Company
AbbVie Inc
AstraZeneca
Amgen Inc
By Type:
Biologic Drugs
Small Molecule Systemic Drugs
Tropical Therapies
By End-User:
Oral
Parenteral
Topical
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Psoriasis Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Psoriasis Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Psoriasis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Psoriasis Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Psoriasis Market Analysis and Outlook to 2022
-
7.1 Global Psoriasis Consumption (2017-2022)
-
7.2 United States Psoriasis Consumption (2017-2022)
-
7.3 Europe Psoriasis Consumption (2017-2022)
-
7.4 China Psoriasis Consumption (2017-2022)
-
7.5 Japan Psoriasis Consumption (2017-2022)
-
7.6 India Psoriasis Consumption (2017-2022)
-
7.7 South Korea Psoriasis Consumption (2017-2022)
8 Region and Country-wise Psoriasis Market Analysis and Outlook to 2028
-
8.1 Global Psoriasis Consumption Forecast (2022-2028)
-
8.2 United States Psoriasis Consumption Forecast (2022-2028)
-
8.3 Europe Psoriasis Consumption Forecast (2022-2028)
-
8.4 China Psoriasis Consumption Forecast (2022-2028)
-
8.5 Japan Psoriasis Consumption Forecast (2022-2028)
-
8.6 India Psoriasis Consumption Forecast (2022-2028)
-
8.7 South Korea Psoriasis Consumption Forecast (2022-2028)
9 Global Psoriasis Market Outlook by Types and Applications to 2022
-
9.1 Global Psoriasis Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biologic Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Small Molecule Systemic Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Tropical Therapies Consumption and Growth Rate (2017-2022)
-
9.2 Global Psoriasis Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Parenteral Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Topical Consumption and Growth Rate (2017-2022)
10 Global Psoriasis Market Outlook by Types and Applications to 2028
-
10.1 Global Psoriasis Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Small Molecule Systemic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Tropical Therapies Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Psoriasis Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Topical Consumption Forecast and Growth Rate (2022-2028)
11 Global Psoriasis Import and Export Analysis (Top 5 Countries)
-
11.1 Global Psoriasis Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Psoriasis Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Psoriasis Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Psoriasis Market Competitive Analysis
-
14.1 Sun Pharma
-
14.1.1 Sun Pharma Company Details
-
14.1.2 Sun Pharma Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sun Pharma Psoriasis Product and Service
-
14.2 UCB
-
14.2.1 UCB Company Details
-
14.2.2 UCB Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 UCB Psoriasis Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Psoriasis Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Psoriasis Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Psoriasis Product and Service
-
14.6 Eli Lilly & Company
-
14.6.1 Eli Lilly & Company Company Details
-
14.6.2 Eli Lilly & Company Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly & Company Psoriasis Product and Service
-
14.7 AbbVie Inc
-
14.7.1 AbbVie Inc Company Details
-
14.7.2 AbbVie Inc Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AbbVie Inc Psoriasis Product and Service
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Details
-
14.8.2 AstraZeneca Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AstraZeneca Psoriasis Product and Service
-
14.9 Amgen Inc
-
14.9.1 Amgen Inc Company Details
-
14.9.2 Amgen Inc Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Amgen Inc Psoriasis Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Psoriasis
-
Figure Psoriasis Picture
-
Table Global Psoriasis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriasis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriasis Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Psoriasis Consumption by Country (2017-2022)
-
Figure United States Psoriasis Consumption and Growth Rate (2017-2022)
-
Table Europe Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure China Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Japan Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure India Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure South Korea Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Consumption Forecast by Country (2022-2028)
-
Figure United States Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Small Molecule Systemic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Tropical Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Parenteral Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Consumption and Growth Rate (2017-2022)
-
Figure Global Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small Molecule Systemic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tropical Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Psoriasis Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Psoriasis Export by Region (Top 5 Countries) (2017-2028)
-
Table Sun Pharma (Foundation Year, Company Profile and etc.)
-
Table Sun Pharma Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharma Psoriasis Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Psoriasis Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Psoriasis Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Psoriasis Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Psoriasis Product and Service
-
Table Eli Lilly & Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly & Company Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly & Company Psoriasis Product and Service
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Psoriasis Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Psoriasis Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Psoriasis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Psoriasis Product and Service
-
